Ibogaine is a naturally occurring psychoactive substance derived from the root bark of the African shrub Tabernanthe iboga. It is primarily used for its potential to interrupt addiction cycles and ...

Texas allocates $50 million to UT-led IMPACT partnership for ibogaine clinical trials treating PTSD, addiction, and more.

Despite support from veterans, a push for more research and efforts to legalize the treatment, much remains unknown about ...

Addiction is a complex condition to treat as genetic, environmental, and psychological factors influence it. Traditional treatment methods include behavioral therapies, medication-assisted treatment ...

Ibogaine, a powerful psychedelic derived from an African shrub long thought to be useful in treating heroin and opiate addiction, was recently the subject of a Stanford study which showed it may also ...

HOLLYWOOD, FL – December 15, 2025 – After months of anticipation, Ibogaine by David Dardashti is excited to announce the official opening and patient intake at its second, newly established facility.

Marc Dervaes journeyed to Mexico for a psychedelic drug that more military veterans are hoping will relieve their trauma.

A new study published in Nature Mental Health provides initial evidence that the psychedelic compound ibogaine may alter brain activity and improve psychiatric symptoms in individuals with a history ...

In a dramatic turn of events that has rocked the psychedelic wellness world, Dr. Carlos Silva, Internal Medicine Specialist and medical director at New Path Specialized Clinic, has published a ...

This month brought an unfortunate development in Kentucky’s efforts to research innovative solutions to the state’s opioid epidemic. W. Bryan Hubbard, head of the Kentucky Opioid Abatement Advisory ...